Meghmani Finechem Limited Logo

Meghmani Finechem Limited

MFL.NS

(2.0)
Stock Price

1.062,00 INR

11.51% ROA

27.78% ROE

15.94x PER

Market Cap.

44.126.312.400,00 INR

82.2% DER

0% Yield

13.13% NPM

Meghmani Finechem Limited Stock Analysis

Meghmani Finechem Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Meghmani Finechem Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (55.07%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

4 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

5 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (9.909) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (6.08x) suggests it's overvalued, potentially making it an expensive investment.

8 DER

The stock is burdened with a heavy load of debt (108%), making it financially unstable and potentially risky for investors.

9 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Meghmani Finechem Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Meghmani Finechem Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Meghmani Finechem Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Meghmani Finechem Limited Revenue
Year Revenue Growth
2017 5.971.089.000
2018 7.100.680.000 15.91%
2019 6.101.721.000 -16.37%
2020 8.259.373.000 26.12%
2021 15.497.332.000 46.7%
2022 21.883.997.000 29.18%
2023 18.195.696.000 -20.27%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Meghmani Finechem Limited Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Meghmani Finechem Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 13.586.000
2018 18.117.000 25.01%
2019 19.817.000 8.58%
2020 38.470.000 48.49%
2021 47.115.000 18.35%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Meghmani Finechem Limited EBITDA
Year EBITDA Growth
2017 2.545.531.000
2018 3.008.569.000 15.39%
2019 1.864.630.000 -61.35%
2020 2.589.449.000 27.99%
2021 5.002.399.000 48.24%
2022 6.969.144.000 28.22%
2023 3.861.876.000 -80.46%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Meghmani Finechem Limited Gross Profit
Year Gross Profit Growth
2017 3.485.338.000
2018 4.411.090.000 20.99%
2019 3.180.399.000 -38.7%
2020 4.134.404.000 23.07%
2021 7.484.002.000 44.76%
2022 10.736.167.000 30.29%
2023 7.226.264.000 -48.57%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Meghmani Finechem Limited Net Profit
Year Net Profit Growth
2017 1.554.745.000
2018 1.828.069.000 14.95%
2019 1.119.977.000 -63.22%
2020 1.008.390.000 -11.07%
2021 2.527.868.000 60.11%
2022 3.532.906.000 28.45%
2023 1.260.284.000 -180.33%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Meghmani Finechem Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 37
2018 44 15.91%
2019 27 -69.23%
2020 24 -8.33%
2021 61 60%
2022 85 29.41%
2023 30 -183.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Meghmani Finechem Limited Free Cashflow
Year Free Cashflow Growth
2017 1.014.263.000
2018 -412.910.000 345.64%
2019 -2.045.772.000 79.82%
2020 324.168.000 731.08%
2021 -1.724.825.000 118.79%
2022 2.097.073.000 182.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Meghmani Finechem Limited Operating Cashflow
Year Operating Cashflow Growth
2017 2.248.937.000
2018 2.613.486.000 13.95%
2019 1.646.824.000 -58.7%
2020 2.292.156.000 28.15%
2021 2.838.167.000 19.24%
2022 6.261.617.000 54.67%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Meghmani Finechem Limited Capital Expenditure
Year Capital Expenditure Growth
2017 1.234.674.000
2018 3.026.396.000 59.2%
2019 3.692.596.000 18.04%
2020 1.967.988.000 -87.63%
2021 4.562.992.000 56.87%
2022 4.164.544.000 -9.57%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Meghmani Finechem Limited Equity
Year Equity Growth
2017 5.173.282.000
2018 4.927.711.000 -4.98%
2019 5.834.706.000 15.54%
2020 6.841.339.000 14.71%
2021 7.259.695.000 5.76%
2022 10.691.002.000 32.1%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Meghmani Finechem Limited Assets
Year Assets Growth
2017 6.708.425.000
2018 10.442.138.000 35.76%
2019 12.734.618.000 18%
2020 14.487.021.000 12.1%
2021 21.236.662.000 31.78%
2022 24.322.353.000 12.69%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Meghmani Finechem Limited Liabilities
Year Liabilities Growth
2017 1.535.143.000
2018 5.514.427.000 72.16%
2019 6.899.912.000 20.08%
2020 7.645.682.000 9.75%
2021 13.976.967.000 45.3%
2022 13.631.351.000 -2.54%

Meghmani Finechem Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
507.73
Net Income per Share
66.64
Price to Earning Ratio
15.94x
Price To Sales Ratio
2.09x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
4.13
EV to Sales
2.5
EV Over EBITDA
8.74
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.06
FreeCashFlow Yield
0
Market Cap
44,13 Bil.
Enterprise Value
52,77 Bil.
Graham Number
621.02
Graham NetNet
-264.4

Income Statement Metrics

Net Income per Share
66.64
Income Quality
0
ROE
0.28
Return On Assets
0.11
Return On Capital Employed
0.27
Net Income per EBT
0.67
EBT Per Ebit
0.85
Ebit per Revenue
0.23
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.46
Operating Profit Margin
0.23
Pretax Profit Margin
0.2
Net Profit Margin
0.13

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.17
Return on Tangible Assets
0.12
Days Sales Outstanding
28.79
Days Payables Outstanding
35.28
Days of Inventory on Hand
67.83
Receivables Turnover
12.68
Payables Turnover
10.35
Inventory Turnover
5.38
Capex per Share
0

Balance Sheet

Cash per Share
8,02
Book Value per Share
257,20
Tangible Book Value per Share
257.2
Shareholders Equity per Share
257.2
Interest Debt per Share
228.91
Debt to Equity
0.82
Debt to Assets
0.36
Net Debt to EBITDA
1.43
Current Ratio
0.65
Tangible Asset Value
10,44 Bil.
Net Current Asset Value
-9,44 Bil.
Invested Capital
0.82
Working Capital
-2,28 Bil.
Intangibles to Total Assets
0.01
Average Receivables
1,91 Bil.
Average Payables
1,12 Bil.
Average Inventory
2391417000
Debt to Market Cap
0.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Meghmani Finechem Limited Dividends
Year Dividends Growth
2023 5

Meghmani Finechem Limited Profile

About Meghmani Finechem Limited

Meghmani Finechem Limited manufactures and sells chlor-alkali and its derivatives in India. The company offers caustic soda, chlorine, hydrogen, caustic potash, chloromethanes, and hydrogen peroxide. It serves refineries, paper and pulp, fluoropolymers, soap and detergent, textile, dyes and pigments, pharmaceuticals, agrochemicals, alumina, PU foams, paints, PTEE pipes, heat resistant pipes, refrigerant gas, water treatment, and electronic industries. The company was incorporated in 2007 and is based in Ahmedabad, India.

CEO
Mr. Kaushal Ashisbhai Soparkar
Employee
936
Address
Meghmani House
Ahmedabad, 380015

Meghmani Finechem Limited Executives & BODs

Meghmani Finechem Limited Executives & BODs
# Name Age
1 Mr. Ankit Natwarlal Patel
Executive Director
70
2 Mr. Darshan Anandbhai Patel
Executive Director
70
3 Mr. Karana Rameshbhai Patel
Executive Director
70
4 Mr. Maulik Jayantibhai Patel
Chairman & MD
70
5 Mr. Kaushal Ashisbhai Soparkar
Chief Executive Officer & Executive Director
70
6 Mr. Sanjay Jain
Chief Financial Officer
70
7 Mr. Kamlesh D. Mehta
Vice President of Company Affairs, Company Sec. & Compliance Officer
70
8 Vijay Vasudeva
Senior Vice President of Operations
70
9 Naresh Kumar Agarwal
Senior Gen. Mang. of Marketing
70
10 Mr. Vikram Bhatt
Senior Gen. Mang. of Corporation Human Relations
70
11 R. S. Rajan
Senior Vice President of Power Plant
70
12 Amritlal Rathod
Head of H2O2 Process
70
13 Jitesh Vaghani
Process Head of Technology
70

Meghmani Finechem Limited Competitors

Jubilant Ingrevia Limited Logo
Jubilant Ingrevia Limited

JUBLINGREA.NS

(2.0)
Ami Organics Limited Logo
Ami Organics Limited

AMIORG.NS

(2.2)
Neogen Chemicals Limited Logo
Neogen Chemicals Limited

NEOGEN.NS

(2.5)